Juliet de Baubigny joined Kleiner Perkins Caufield & Byers in 2001 as one of Silicon Valley’s first venture capital partners focused on leveraging the firm’s broad network and deep relationships to help entrepreneurs recruit the best talent and build iconic companies. Juliet is sought after by entrepreneurs for her expansive global network and strategic guidance in the areas of human capital strategy including executive leadership, talent, recruiting, compensation, corporate governance and team building.
Throughout her career, Juliet has contributed to building high-performance management teams at companies including Google, Amazon, DocuSign, Bloom Energy, Shazam, Chegg and One Kings Lane. At KPCB, Juliet has led the development of several key initiatives including Kleiner Perkins Women Leaders (KPWL), an initiative aimed at mentoring and developing the next generation of female entrepreneurs, and the KPCB Fellows Program, a program that brings the most talented engineering, design, and product management students into KPCB portfolio companies. Juliet is a frequent contributor to Fortune as a Fortune Most Powerful Women Insider. She also appears often on Bloomberg TV, where she is an expert on Silicon Valley’s “War for Talent” as well as on millennials in the workplace, women in technology, and developing cultures of innovation.
Before joining KPCB, Juliet was a managing director of Ramsey Beirne Associates, a leading provider of executive searches to high-growth, leading-edge companies. Earlier in her career, Juliet was a partner at Heidrick & Struggles, a global executive search firm where she led CEO and VP level searches. Juliet began her career with Procter & Gamble in the United Kingdom.
Juliet earned her bachelor’s degree in business from Newcastle Business School at Northumbria University in the United Kingdom. Juliet is also a passionate champion of innovation in philanthropy, contributing to leading organizations such as Product (RED), acting as a co-chair of Chime for Change’s ChimeHack, and most recently, co-founding Beyond Type 1, an organization focused on finding a cure for Type 1 diabetes.